NCT01863602View on ClinicalTrials.gov

Special Drug Use Investigation for LAMICTAL® (Long Term)

CompletedOBSERVATIONAL

Enrollment

850

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions

Epilepsy

Interventions

DRUG

Lamotrigine tablets

Administered for long-term according to the prescribing information in the locally approved label by the authorities.

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY